Stay updated on Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedA system-wide notice about a lapse in government funding and NIH operating status was added at the top, and the revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check88 days agoChange DetectedGlossary visibility was added and revision metadata updated to v3.4.0, with the new display of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' labels; the old 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' labels and revision v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG post-ablation in UUTTCC Clinical Trial page.